Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

An mRNA-based flu vaccine has the potential advantage to more precisely match circulating strains, support rapid response in a future influenza pandemic, and pave the way for COVID-19 combination ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...

Tattoos have become a form of self-expression. Unfortunately, observers mostly misread these inky cues and misjudge the ...

Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking ...

Moderna is preparing to test Health Secretary Robert F. Kennedy Jr.'s tougher vaccine policies with a combination flu-COVID ...

The S&P 500 added 0.5% on Wednesday, July 2, 2025, reaching a record-high close for the second time this week as the U.S. announced a trade deal with Vietnam.

The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

A top official at the Food and Drug Administration recently overruled government scientists on the availability of two ...

Tariffs, uncertainty, and inflation crimped stocks in first half of 2025 after AI frenzy and strong earnings sent Nasdaq up 18% in 2024. Bet on companies Trump favors.